Log in to save to my catalogue

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomog...

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomog...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A653614089

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Recognizing clinical manifestations heralding the development of Alzheimer's disease (AD)-related cognitive impairment could improve the identification of individuals at higher risk of AD who may benefit from potential prevention strategies targeting preclinical population. We aim to characterize the association of body weight change with cognitive...

Alternative Titles

Full title

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A653614089

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A653614089

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-021-00781-z

How to access this item